Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 18 results when searching "Ciclosporin"

DOCUMENT

01/02/2023 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 1 February 2023 Page 1 of 16 East Region Formulary Committee Minutes Date: 1 February 2023 Time: 2pm – 4pm Location: MS Teams Present: Ruth Cameron Advance...

DOCUMENT

29/03/2023 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 29 March 2023 Page 1 of 16 East Region Formulary Committee Minutes Date: 29 March 2023 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning (Acting) A...

DOCUMENT

13/05/2026 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 13 May 2026 Page 1 of 15 East Region Formulary Committee Minutes Date: 13 May 2026 Time: 2.00pm – 4:20pm Location: MS Teams Present: Mona Boriceanu Advanced N...

DOCUMENT

24/11/2021 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 24 November 2021 Page 1 of 24 East Region Formulary Committee Minutes Date: 24 November 2021 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning Lead P...

FORMULARY DECISION

Ciclosporin : Cequa

SMC2739 : Treatment of moderate-to-severe Dry Eye Disease (keratoconjunctivitis sicca) in adult patients who have not responded adequately to artificial tears. SMC restriction: severe keratitis in ad...

FORMULARY DECISION

Ciclosporin : Vevizye

SMC2873 : Treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca) in adult patients, which has not improved despite treatment with tear substitutes. SMC restriction: severe kerat...

FORMULARY DECISION

Ciclosporin : Ikervis

1089/15 : Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.

FORMULARY DECISION

Ciclosporin : Verkazia

SMC2111 : Treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents (until the age of 18)